Stay updated on Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Sign up to get notified when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Access to the study record is blocked, as the page now renders a 403 Forbidden error instead of the study details. The interface shows the 403 message and site footer, with the previous content no longer visible.
    Difference
    19%
    Check dated 2026-09-21T23:57:26.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The revision label on the page has been updated from v3.6.5 to v3.6.6, indicating a newer version of the page content. This is a metadata update and does not affect the study details or participant information.
    Difference
    0.1%
    Check dated 2026-08-31T18:45:42.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, signaling a minor backend/template update to the page.
    Difference
    0.1%
    Check dated 2026-08-10T16:22:40.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Type 2 diabetes was added as a topic and 'related topics: MedlinePlus Genetics' were added in the page's contextual links. The site revision label was updated from v3.6.3 to v3.6.4 in the footer.
    Difference
    0.2%
    Check dated 2026-07-27T06:35:05.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Type 2 diabetes and related topic references, including MedlinePlus Genetics, have been removed from the page, reducing the explicit disease context shown to readers. The change affects how the study's condition is described and what related resources are visible to users.
    Difference
    0.2%
    Check dated 2026-07-20T02:20:41.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page now references Type 2 diabetes more prominently in its related topics and adds MedlinePlus Genetics as a related resource, broadening context and cross-linking to genetic information. This change improves navigation and thematic connections without changing the study's data or primary descriptions.
    Difference
    0.2%
    Check dated 2026-07-12T22:26:57.000Z thumbnail image

Stay in the know with updates to Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.